skip to main content

COPD inhaler pneumonia risk — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory TherapeuticsCOPD inhaler pneumonia riskGPhC CRA

A 76-year-old man with COPD is using fluticasone/salmeterol and tiotropium. He has had two episodes of pneumonia in the past year and no clear asthma features. The GP asks for a medicines optimisation view. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Review whether inhaled corticosteroid therapy remains appropriate

Inhaled corticosteroids in COPD can increase the risk of pneumonia, particularly at higher doses and in susceptible patients. Ongoing need should be reviewed against exacerbation history, eosinophils and asthma features. Long-acting bronchodilation remains central to COPD symptom management.

Reference: BNF; NICE CKS